science
plus
.abes.fr
|
explorer
À propos de :
Saag Michael
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Saag Michael
Saag Michael S.
Saag Michael S
personal mailbox
msaag@uab.edu
familyName
Saag
Given name
Michael
Michael S.
Michael S
is
relates
of
http://hub.abes.fr/oup/periodical/cid/2000/volume_31/issue_4/101086318143/authorship/2
http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_10/101086598169/authorship/7
http://hub.abes.fr/oup/periodical/cid/2006/volume_43/issue_10/101086508664/authorship/1
http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_5/101086520653/authorship/7
http://hub.abes.fr/oup/periodical/cid/2008/volume_46/issue_7/101086529382/authorship/1
http://hub.abes.fr/oup/periodical/ije/2007/volume_36/issue_2/101093ijedyl286/authorship/3
http://hub.abes.fr/oup/periodical/jid/2010/volume_201/issue_6/101086650697/authorship/6
http://hub.abes.fr/oup/periodical/aje/2010/volume_171/issue_2/101093ajekwp347/authorship/6
http://hub.abes.fr/oup/periodical/cid/2010/volume_50/issue_4/101086650004/authorship/9
http://hub.abes.fr/oup/periodical/jid/2001/volume_183/issue_3/101086318078/authorship/2
http://hub.abes.fr/oup/periodical/jid/2008/volume_198/issue_9/101086592169/authorship/2
http://hub.abes.fr/oup/periodical/cid/2000/volume_30/issue_4/101086313757/authorship/1
http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_6/101086597093/authorship/10
http://hub.abes.fr/oup/periodical/cid/2006/volume_42/issue_6/101086500206/authorship/3
http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_10/101086644768/authorship/4
http://hub.abes.fr/oup/periodical/jid/2006/volume_194/issue_5/101086506364/authorship/4
http://hub.abes.fr/oup/periodical/cid/2000/volume_30/issue_5/101086313765/authorship/10
http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_supplement4/101086522548/authorship/1
http://hub.abes.fr/oup/periodical/jid/2003/volume_188/issue_5/101086377311/authorship/8
http://hub.abes.fr/oup/periodical/cid/2010/volume_51/issue_2/101086653678/authorship/1
http://hub.abes.fr/oup/periodical/cid/2004/volume_38/issue_10/101086383031/authorship/6
http://hub.abes.fr/oup/periodical/cid/2006/volume_42/issue_1/101086498348/authorship/2
http://hub.abes.fr/oup/periodical/cid/2006/volume_42/issue_7/101086500453/authorship/12
http://hub.abes.fr/oup/periodical/cid/2010/volume_50/issue_11/101086652650/authorship/8
http://hub.abes.fr/oup/periodical/cid/2010/volume_51/issue_6/101086655890/authorship/8
http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_1/101086518587/authorship/10
http://hub.abes.fr/oup/periodical/cid/1999/volume_28/issue_2/101086515110/authorship/1
http://hub.abes.fr/oup/periodical/cid/2003/volume_37/issue_5/101086377271/authorship/10
http://hub.abes.fr/oup/periodical/cid/2004/volume_39/issue_9/101086424883/authorship/8
http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_2/101086595705/authorship/9
http://hub.abes.fr/oup/periodical/jid/2009/volume_199/issue_11/101086598965/authorship/1
http://hub.abes.fr/oup/periodical/jid/2010/volume_201/issue_10/101086652190/authorship/4
http://hub.abes.fr/oup/periodical/cid/2005/volume_41/issue_1/101086430835/authorship/3
http://hub.abes.fr/oup/periodical/gerona/2008/volume_63/issue_4/101093gerona634331/authorship/11
http://hub.abes.fr/oup/periodical/cid/2007/volume_44/issue_1/101086510072/authorship/6
http://hub.abes.fr/oup/periodical/ije/2008/volume_37/issue_5/101093ijedym231/authorship/13
http://hub.abes.fr/oup/periodical/ije/2009/volume_38/issue_3/101093ijedyp004/authorship/11
is
Author
of
Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse-Transcriptase-Inhibitor Therapy in Clinical Practice
Nucleoside Reverse-Transcriptase Inhibitor Dosing Errors in an Outpatient HIV Clinic in the Electronic Medical Record Era
How Do HIV Elite Controllers Do What They Do?
Which Policy to ADAP-T: Waiting Lists or Waiting Lines?
A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis
Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection
Duration of Highly Active Antiretroviral Therapy Regimens
Phenotypic Drug Susceptibility Testing Predicts Long-Term Virologic Suppression Better than Treatment History in Patients with Human Immunodeficiency Virus Infection
Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults
Can Routine Clinical Markers Be Used Longitudinally to Monitor Antiretroviral Therapy Success in Resource-Limited Settings?
Opt-Out Testing: Who Can Afford to Take Care of Patients with Newly Diagnosed HIV Infection?
Evidence That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC-HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068
Comparative Efficacy versus Effectiveness of Initial Antiretroviral Therapy in Clinical Trials versus Routine Care
A Randomized Trial of 2 Different 4-Drug Antiretroviral Regimens versus a 3-Drug Regimen, in Advanced Human Immunodeficiency Virus Disease
A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1
Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
Trends in AIDS-Defining and Non—AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002
Practice Guidelines for the Management of Cryptococcal Disease
Week-12 Response to Therapy as a Predictor of Week 24, 48, and 96 Outcome in Patients Receiving the HIV Fusion Inhibitor Enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) Trials
Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced Patients with HIV Infection in North America
The Biological Sciences Section Program at the 60th Annual Meeting of The Gerontological Society of America
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Uncompensated Medical Provider Costs Associated with Prior Authorization for Prescription Medications in an HIV Clinic
Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia
Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada
Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-tropic HIV-1 Infection
Failure to Establish HIV Care: Characterizing the "No Show" Phenomenon
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody
Reply to Dal Maso et al
Distribution of Health Care Expenditures for HIV-Infected Patients
High Sensitivity of Human Leukocyte Antigen-B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
Missed Visits and Mortality among Patients Establishing Initial Outpatient HIV Treatment
Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus
HIV Policy: The Path Forward—A Joint Position Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
